orphenadrine citrate

Generic: orphenadrine citrate

Labeler: sandoz inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name orphenadrine citrate
Generic Name orphenadrine citrate
Labeler sandoz inc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

orphenadrine citrate 100 mg/1

Manufacturer
Sandoz Inc

Identifiers & Regulatory

Product NDC 0185-0022
Product ID 0185-0022_de0e8cdb-788a-4ebe-969d-14d44a14ddc2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040327
Marketing Start 2000-02-15
Marketing End 2027-03-20

Pharmacologic Class

Classes
centrally-mediated muscle relaxation [pe] muscle relaxant [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01850022
Hyphenated Format 0185-0022

Supplemental Identifiers

RxCUI
994521
UNII
X0A40N8I4S

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name orphenadrine citrate (source: ndc)
Generic Name orphenadrine citrate (source: ndc)
Application Number ANDA040327 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0185-0022-01)
source: ndc

Packages (1)

Ingredients (1)

orphenadrine citrate (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "de0e8cdb-788a-4ebe-969d-14d44a14ddc2", "openfda": {"unii": ["X0A40N8I4S"], "rxcui": ["994521"], "spl_set_id": ["239018ff-cec6-46de-ae9d-26c9ec034a32"], "manufacturer_name": ["Sandoz Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0185-0022-01)", "package_ndc": "0185-0022-01", "marketing_end_date": "20270320", "marketing_start_date": "20000215"}], "brand_name": "Orphenadrine Citrate", "product_id": "0185-0022_de0e8cdb-788a-4ebe-969d-14d44a14ddc2", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "0185-0022", "generic_name": "Orphenadrine Citrate", "labeler_name": "Sandoz Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Orphenadrine Citrate", "active_ingredients": [{"name": "ORPHENADRINE CITRATE", "strength": "100 mg/1"}], "application_number": "ANDA040327", "marketing_category": "ANDA", "marketing_end_date": "20270320", "marketing_start_date": "20000215"}